Biochemical characterization of LR769, a new recombinant factor VIIa bypassing agent produced in the milk of transgenic rabbits.

Guillaume ChevreuxN TillyY LeblancC RamonV FaidM MartinF DhainautN Bihoreau

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2017)

The innovative expression system used to produce LR769 yields a new safe and effective rhFVIIa for the treatment of haemophilia A or B patients with inhibitors.

Keyphrases

poor prognosis
binding protein
combination therapy